pRb-independent growth arrest and transcriptional regulation of E2F target genes

Neoplasia

Volumn 7, Issue 2, 2005, Pages 141-151

  McCabe, Michael T ^a,b   Azih, Odinaka J ^b   Day, Mark L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

E2F; Microarray; pRb; Prostate; Retinoblastoma

Indexed keywords

RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL POPULATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EPITHELIUM CELL; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; REGULATORY MECHANISM; SERUM; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; WILD TYPE;

EID: 14644400472     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04394     Document Type: Article

References (52)

1. Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE, and Lee WH (1990). Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87, 7762-7766.
2. Buchkovich K, Duffy LA, and Harlow E (1989). The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097-1105.
3. Chen PL, Scully P, Shew JY, Wang JY, and Lee WH (1989). Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 1193-1198.
4. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, and Livingston DM (1989). The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58, 1085-1095.
5. Akiyama T and Toyoshima K (1990). Marked alteration in phosphorylation of the RB protein during differentiation of human promyelocytic HL60 cells. Oncogene 5, 179-183.
6. Coppola JA, Lewis BA, and Cole MD (1990). Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene 5, 1731-1733.
7. Futreal PA and Barrett JC (1991). Failure of senescent cells to phosphorylate the RB protein. Oncogene 6, 1109-1113.
8. Day ML, Foster RG, Day KC, Zhao X, Humphrey P, Swanson P, Postigo SH, Zhang SH, and Dean DC (1997). Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J Biol Chem 272, 8125-8128.
9. Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung YK, and Israel MA (1995). Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 14, 461-472.
10. Morris EJ and Dyson NJ (2001). Retinoblastoma protein partners. Adv Cancer Res 82, 1-54.
11. Stevens C and La Thangue NB (2003). E2F and cell cycle control: a double-edged sword. Arch Biochem Biophys 412, 157-169.
12. Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S, Watson RJ, te Riele H, and Dynlacht BD (2002). E2F mediates cell cycle - dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev 16, 933-947.
13. de la Luna S, Burden MJ, Lee CW, and La Thangue NB (1996). Nuclear accumulation of the E2F heterodimer regulated by subunit composition and alternative splicing of a nuclear localization signal. J Cell Sci 109 (Part 10), 2443-2452.
14. Lindeman GJ, Gaubatz S, Livingston DM, and Ginsberg D (1997). The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci USA 94, 5095-5100.
15. Magae J, Wu CL, Illenye S, Harlow E, and Heintz NH (1996). Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J Cell Sci 109 (Part 7), 1717-1726.
16. Polager S, Kalma Y, Berkovich E, and Ginsberg D (2002). E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene 21, 437-446.
17. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, and Dynlacht BD (2002). E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16, 245-256.
18. Grana X, Garriga J, and Mayol X (1998). Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17, 3365-3383.
19. Trimarchi JM, Fairchild B, Verona R, Moberg K, Andon N, and Lees JA (1998). E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc Natl Acad Sci USA 95, 2850-2855.
20. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, and te Riele H (1992). Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330.
21. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, and Weinberg RA (1992). Effects of an Rb mutation in the mouse. Nature 359, 295-300.
22. LeCouter JE, Kablar B, Whyte PF, Ying C, and Rudnicki MA (1998). Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125, 4669-4679.
23. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, and Bradley A (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294.
24. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, and Jacks T (1996). Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev 10, 1621-1632.
25. Maandag EC, van der Valk M, Vlaar M, Feltkamp C, O'Brien J, van Roon M, van der Lugt N, Berns A, and te Riele H (1994). Developmental rescue of an embryonic - lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J 13, 4260-4268.
26. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, Dannenberg JH, Berns A, and te Riele H (1998). p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12, 1599-1609.
27. Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, Weinberg RA, and Jacks T (1994). Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J 13, 4251-4259.
28. Harrison DJ, Hooper ML, Armstrong JF, and Clarke AR (1995). Effects of heterozygosity for the Rb-1t19neo allele in the mouse. Oncogene 10, 1615-1620.
29. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, and Jacks T (1996). Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10, 1633-1644.
30. Classon M, Salama S, Gorka C, Mulloy R, Braun P, and Harlow E (2000). Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. Proc Natl Acad Sci USA 97, 10820-10825.
31. Dannenberg JH, van Rossum A, Schuijff L, and te Riele H (2000). Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 14, 3051-3064.
32. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, Theodorou E, and Jacks T (2000). Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 14, 3037-3050.
33. Wang Y, Hayward SW, Donjacour AA, Young P, Jacks T, Sage J, Dahiya R, Cardiff RD, Day ML, and Cunha GR (2000). Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res 60, 6008-6017.
34. Day KC, McCabe MT, Zhao X, Wang Y, Davis JN, Phillips J, Von Gelden M, Ried T, Kukuruga MA, Cunha GR, et al. (2002). Rescue of embryonic epithelium reveals that homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality, but does not influence epithelial differentiation or tissue morphogenesis. J Biol Chem 277, 44475-44484.
35. Zheng L and Lee WH (2001). The retinoblastoma gene: a prototypic and multifunctional tumor suppressor. Exp Cell Res 264, 2-18.
36. Garriga J, Limon A, Mayol X, Rane SG, Albrecht JH, Reddy EP, Andres V, and Grana X (1998). Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. Biochem J 333 (Part 3), 645-654.
37. Cho RJ, Huang M, Campbell MJ, Dong H, Steinmetz L, Sapinoso L, Hampton G, Elledge SJ, Davis RW, and Lockhart DJ (2001). Transcriptional regulation and function during the human cell cycle. Nat Genet 27, 48-54.
38. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M, and Nevins JR (2001). Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 21, 4684-4699.
39. van der Meijden CM, Lapointe DS, Luong MX, Peric-Hupkes D, Cho B, Stein JL, van Wijnen AJ, and Stein GS (2002). Gene profiling of cell cycle progression through S-phase reveals sequential expression of genes required for DNA replication and nucleosome assembly. Cancer Res 62, 3233-3243.
40. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, and Clarke MF (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302-305.
41. Callaghan DA, Dong L, Callaghan SM, Hou YX, Dagnino L, and Slack RS (1999). Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity. Dev Biol 207, 257-270.
42. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, and Jacks T (2003). Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223-228.
43. Ma Y, Croxton R, Moorer RL Jr, and Cress WD (2002). Identification of novel E2F1-regulated genes by microarray. Arch Biochem Biophys 399, 212-224.
44. Markey MP, Angus SP, Strobeck MW, Williams SL, Gunawardena RW, Aronow BJ, and Knudsen ES (2002). Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Res 62, 6587-6597.
45. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, and Helin K (2001). E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15, 267-285.
46. Vernell R, Helin K, and Muller H (2003). Identification of target genes of the p16INK4A-pRB-E2F pathway. J Biol Chem 278, 46124-46137.
47. Weinmann AS, Yan PS, Oberley MJ, Huang TH, and Farnham PJ (2002). Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 16, 235-244.
48. Hurford RK Jr, Cobrinik D, Lee MH, and Dyson N (1997). pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 11, 1447-1463.
49. Black EP, Huang E, Dressman H, Rempel R, Laakso N, Asa SL, Ishida S, West M, and Nevins JR (2003). Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res 63, 3716-3723.
50. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lassar AB, and Kaelin WG Jr (1998). Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 12, 95-106.
51. Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, and Jacks T (1998). Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 2, 293-304.
52. Yamasaki L, Bronson R, Williams BO, Dyson NJ, Harlow E, and Jacks T (1998). Loss of E2F-1 reduces tumorigenesis and extends the life-span of Rb1(+/-)mice. Nat Genet 18, 360-364.